NCT00223197View on ClinicalTrials.gov

Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

April 30, 2006

Conditions
Bipolar DisorderMajor Depressive DisorderSubstance Abuse
Interventions
DRUG

Pregnenolone

Trial Locations (1)

75390

The University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

University of Texas Southwestern Medical Center

OTHER

NCT00223197 - Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse | Biotech Hunter | Biotech Hunter